Comparative Analysis of the Microcirculation During Cardiac Surgery With Minimal Invasive Versus Conventional Extracorporeal Circulation

January 31, 2023 updated by: Kyriakos Anastasiadis, Aristotle University Of Thessaloniki
The aim of the proposed study is to evaluate microcirculatory alterations in patients undergoing open heart surgery with minimal invasive versus conventional extracorporeal circulation. Positive clinical results evidenced with goal-directed perfusion and cerebral oximetry monitoring could be attributed to preserved microcirculation at tissue level.

Study Overview

Detailed Description

The aim of the proposed study is to evaluate microcirculatory alterations in patients undergoing open heart surgery with minimal invasive versus conventional extracorporeal circulation.

Microcirculatory changes during cardiac surgery have been investigated mainly during coronary procedures using the conventional extracorporeal circulation.There is no single study in the literature investigating microcirculatory alterations using a perioperative strategy of "physiologic" perfusion.

Positive clinical results evidenced with goal-directed perfusion and cerebral oximetry monitoring could be attributed to preserved microcirculation at tissue level.

All patients will follow the same anaesthetic and perfusion protocol. The patients will be randomized to two arms:

  1. Patients operated with Minimal Invasive Extracorporeal Circulation (MiECC)
  2. Patients operated with conventional cardiopulmonary bypass (cCPB)

The protocol for the evaluation of microcirculation will be based on:

  • Cerebral near-infrared spectroscopy (rScO2) measurements (INVOS, Covidien-Medtronic Inc.).
  • NIRS-Based Cerebral Autoregulation Monitoring: Analog arterial blood pressure signals will be digitized and then processed with the digital NIRS signals using a personal computer and a special ICM software (University of Cambridge, Cambridge, UK). Monitoring cerebral autoregulation ensures adequate renal perfusion. Hence, brain can be used not just as a target but also as an index organ indicating adequacy of perfusion.
  • Somatic near-infrared spectroscopy (rSsO2) measurements (INVOS, Covidien-Medtronic Inc.).
  • Sublingual mucosal microcirculation measurements during surgery using side dark field (SDF) imaging (MicroScan, Microvision Medical, Amsterdam, The Netherlands).

All measurements will be performed at the following time points:

T0: after induction of anaesthesia T1: after initiation of cardiopulmonary bypass T2: 10 minutes after cross- clamping the aorta T3: 10 minutes before removing the aortic cross-clamp T4: after weaning from extracorporeal circulation

Study Type

Interventional

Enrollment (Anticipated)

60

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Thessaloníki, Greece, 54636
        • Recruiting
        • Cardiothoracic Department, AHEPA University Hospital
        • Contact:
          • Kyriakos Anastasiadis, Professor
          • Phone Number: +30 2310994845
          • Email: anastasi@auth.gr
        • Contact:
          • Polychronis Antonitsis, Assoc. Prof.
          • Phone Number: +30 2310 994871
          • Email: antonits@auth.gr
        • Sub-Investigator:
          • Helena Argiriadou, Assoc. Prof.

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 85 years (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • patients undergoing undergoing open heart surgery with accepted indications under extracorporeal circulation

Exclusion Criteria:

  • patients undergoing emergency surgery
  • patients in preoperative cardiogenic shock with evidence of tissue malperfusion
  • patients with severe peripheral vascular disease
  • patients unable to give informed consent

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: DIAGNOSTIC
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: SINGLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
ACTIVE_COMPARATOR: Minimal Invasive Extracorporeal Circulation (MiECC)
Patients undergoing cardiac surgery with Minimal Invasive Extracorporeal Circulation.
Cerebral oximetry monitoring with near-infrared spectroscopy.
Tissue perfusion monitoring with somatic near-infrared spectroscopy.
Cerebral autoregulation monitoring with COx.
Evaluation of microcirculation with sublingual microscopy.
ACTIVE_COMPARATOR: Conventional cardiopulmonary Bypass (cCPB)
Patients undergoing cardiac surgery with conventional cardiopulmonary bypass.
Cerebral oximetry monitoring with near-infrared spectroscopy.
Tissue perfusion monitoring with somatic near-infrared spectroscopy.
Cerebral autoregulation monitoring with COx.
Evaluation of microcirculation with sublingual microscopy.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Proportion of perfused vessels assessed with sublingual microscopy
Time Frame: During surgery, from induction of anesthesia to weaning of extracorporeal circulation
Proportion of perfused vessels (PPV) assessed with sublingual microscopy.
During surgery, from induction of anesthesia to weaning of extracorporeal circulation
Total vessel density assessed with sublingual microscopy
Time Frame: During surgery, from induction of anesthesia to weaning of extracorporeal circulation
Total vessel density (TVD) assessed with sublingual microscopy.
During surgery, from induction of anesthesia to weaning of extracorporeal circulation
Perfused vessel density assessed with sublingual microscopy
Time Frame: During surgery, from induction of anesthesia to weaning of extracorporeal circulation
Perfused vessel density (PVD) assessed with sublingual microscopy.
During surgery, from induction of anesthesia to weaning of extracorporeal circulation

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Cerebral oximetry
Time Frame: During surgery, from induction of anesthesia to weaning of extracorporeal circulation
Change in cerebral oxygen saturation during cardiac surgery assessed with near-infrared spectroscopy
During surgery, from induction of anesthesia to weaning of extracorporeal circulation
Peripheral tissue oximetry
Time Frame: During surgery, from induction of anesthesia to weaning of extracorporeal circulation
Change in tissue perfusion during cardiac surgery assessed with near-infrared spectroscopy
During surgery, from induction of anesthesia to weaning of extracorporeal circulation
Cox index assessed with near-infrared spectroscopy
Time Frame: During surgery, from induction of anesthesia to weaning of extracorporeal circulation
Evaluation of cerebral autoregulation during cardiac surgery with continuous monitoring of Cox index (ICM+ software, Cambridge, UK).
During surgery, from induction of anesthesia to weaning of extracorporeal circulation

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Kyriakos Anastasiadis, Prof., Aristotle University of Thessaloniki, School of Medicine
  • Principal Investigator: Helena Argiriadou, Assoc. Prof., Aristotle University of Thessaloniki, School of Medicine

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

December 1, 2021

Primary Completion (ANTICIPATED)

December 31, 2023

Study Completion (ANTICIPATED)

December 31, 2023

Study Registration Dates

First Submitted

July 22, 2022

First Submitted That Met QC Criteria

July 26, 2022

First Posted (ACTUAL)

July 29, 2022

Study Record Updates

Last Update Posted (ACTUAL)

February 1, 2023

Last Update Submitted That Met QC Criteria

January 31, 2023

Last Verified

January 1, 2023

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Coronary Artery Disease

Clinical Trials on Cerebral oximetry

3
Subscribe